EBAC

European Biotech Acquisition Corp.

USD

	Dec '21	Dec '22
revenue
cost of revenue
gross profit
selling and marketing expenses
general and administrative expenses	1.10M -	2.79M 153.22%
selling general and administrative expenses	1.10M -	2.79M 153.22%
research and development expenses
other expenses		32.94K -
cost and expenses	1.10M -	2.82M 156.21%
operating expenses	1.10M -	2.82M 156.21%
interest expense		-3.16M -
ebitda	-3.68M -	-5.98M 62.54%
operating income	-1.10M -	-2.82M 156.21%
depreciation and amortization	-2.58M -	-3.16M 22.58%
total other income expenses net	2.58M -	3.16M 22.58%
income before tax	1.48M -	342.89K 76.81%
income tax expense		-3.16M -
net income	1.48M -	3.50M 136.95%
weighted average shs out	13.66M -	12.75M 6.66%
weighted average shs out dil	13.66M -	12.75M 6.66%
eps	0.43 -	0.27 37.21%
epsdiluted	0.11 -	0.27 145.45%

All numbers in USD (except ratios and percentages)